An underground market for unapproved slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Drug Gaining Popularity Via Social Media
Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are urged to message these accounts privately for source information, while also receiving promotional offers.
Active Trade on Social Networks
Additionally, a flourishing market exists on Telegram, where communities with thousands of members share comparison photos, injection guides and assertions of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Healthcare Professionals Express Concerns
However, physicians and pharmacists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.
Several experts stated the popularity for the experimental drug could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the British medical regulations.
Some content creators try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach medicines, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.
Platform Response and Content Removal
Based on TikTok, the platform has removed violative content and prohibited associated keywords and search suggestions. The company stated it was dedicated to keeping the platform secure and allocating resources in enhancing enforcement strategies.
Digital Trading Operations
Investigations also discovered communities with up to 9,000 members selling retatrutide using the platform's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly displays groups with numerous of users, populated with photos of weight loss, glowing reviews and detailed instructions for mixing or administering at home.
Within minutes of joining one group, a seller shared contact information, where the majority of purchases take place. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about weight, health issues or previous experience.
Item Information and Costs
Inside these groups, messages display dark colored packages with postal service stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20 milligrams. When asked how much time a pen should last, sellers give contradictory responses ranging from a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for Telegram said it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering substances they cannot confirm. Although the science behind retatrutide is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the increase in interest to recent price rises for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.
Her staff has previously encountered individuals injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These substances could be impure or improperly measured.”
Producer Position
A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company experimental product not yet approved … may expose users to potentially serious health risks”.
